Early Results On Alzheimer's Vaccine Trial In People With Down Syndrome Promising, Researchers Say

“This is the first vaccine targeting Abeta that has been tested in the Down syndrome population,” said Prof. Andrea Pfeifer, CEO of AC Immune, adding that she believes studying the Down syndrome population is critical for developing successful treatments for everyone with Alzheimer’s.